CN Patent

CN115666579B — 卡非佐米的稳定的即稀释型制剂

Assigned to Kashif Bioscience Co ltd · Expires 2025-10-28 · 1y expired

What this patent protects

本发明提供了包含卡非佐米或其药学上可接受的衍生物的室温稳定的即稀释型可注射制剂。本发明还提供了通过给予包含卡非佐米或其药学上可接受衍生物的室温稳定的即稀释型可注射制剂来对患有多发性骨髓瘤的患者进行治疗的方法。

USPTO Abstract

本发明提供了包含卡非佐米或其药学上可接受的衍生物的室温稳定的即稀释型可注射制剂。本发明还提供了通过给予包含卡非佐米或其药学上可接受衍生物的室温稳定的即稀释型可注射制剂来对患有多发性骨髓瘤的患者进行治疗的方法。

Drugs covered by this patent

Patent Metadata

Patent number
CN115666579B
Jurisdiction
CN
Classification
—
Expires
2025-10-28
Drug substance claim
No
Drug product claim
No
Assignee
Kashif Bioscience Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.